M20 M23 M43 S33 S43 S83
Conditions
Sponsors
Mawendo GmbH
Eligibility
Sex/Gender
All
Age
12 Years to No maximum
Inclusion criteria
Inclusion criteria: ICD-10 codes mentioned above
Exclusion criteria
Exclusion criteria: 1. Minors: Children under the age of 12 are excluded. Persons under the age of 18 require the consent of a legal representative. 2. Health requirements: Medical conditions outside the selected indication of the training program/physiotherapy may pose a risk to participation in the services provided by Mawendo or the physiotherapy. These are considered exclusion criteria if they are classified as questionable for the physical exercises of the training programs or physiotherapy. Medical clarification is therefore necessary before starting training or physiotherapy. These are in particular a) Previous operations in the period up to six months before the start of treatment in connection with one of the indications examined b) Severe or acute illnesses of the cardiovascular system (e.g. acute heart attack, acute ischemic heart disease, high blood pressure with cardiac insufficiency, hypertensive crisis) c) Diseases of the lungs or respiratory tract (e.g. pneumonia, pulmonary embolism) d) Tumor diseases (e.g. malignant neoplasms of the bone and articular cartilage, malignant neoplasms of internal organs) e) Infections and fever (e.g. rheumatic fever, purulent arthritis, sepsis, bacterial infections) f) Injuries or diseases of the musculoskeletal system outside the indication for the training program g) Bleeding tendencies (history of increased bleeding or taking anticoagulant medication) h) Mental disorders (e.g. acute psychosis) i) Pregnancy Other conditions not listed here may also mean that a patient is not suitable for participation in a Mawendo training program or physiotherapy treatment. Before treatment, the prescribing doctor will therefore clarify whether the physiotherapy or the exercises used in the Mawendo training program can be carried out safely. Otherwise there is a contraindication. 3. Visual acuity: The Mawendo application is not suitable for users with severe visual impairments. 4. Pain intensity before the start of treatment: To avoid bias, patients with either very little or very severe pain at the start of treatment are excluded. The pain level will be assessed by the recruiting physician on a Verbal Numerical Rating Scale (VRNS, value range 0-10, Mohan et al. (2010)) before study inclusion. Patients with scores = 2 or = 8 on the VNRS will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Functional improvement, measured by Patient Reported Outcomes. The following measurement methods/questionnaires are used for specific diagnoses: Knee Osteoarthritis Outcome Score (KOOS), Oswestry Disability Index (ODI), Western Ontario Shoulder Instability Index (WOSI), Foot Function Index (FFI). 2. Reduction of pain, measured by visual analog scale (VAS). The primary endpoints will be assessed in the treatment groups before and after the approximately 12-week treatment period. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome | — |
Countries
Germany
Outcome results
None listed